Soluble lipofuscin in commercially-available human serum albumin solutions.
Two studied commercial human serum albumin solutions had developed yellow colors during storage. These yellow materials were isolated and shown to be soluble lipofuscin. Aqueous solutions of this lipofuscin exhibited fluorescence spectra with 355 nm excitation and 432 nm emission maxima. After acid hydrolysis of this lipofuscin a nonhydrolysable lipid-melanin fraction was obtained. Ethanol-ether extraction yielded a lipid-containing solution. When evaporated and mixed with water, a solution-suspension was obtained that produced very similar fluorescence spectra to those described above, with 368 nm excitation and 432 nm emission maxima. The separated melanin component was not fluorescent. The isolated lipofuscin exhibited a weak electron paramagnetic resonance spectrum and its g-value has been found to be 2.0069 and its line width 9.8 G. The albumin solution contained approximately 0.23 g of melanin precipitate per 9.31 g of soluble lipofuscin isolated from 25 g of albumin. The deleterious cardiac, pulmonary, renal and clotting changes associated with the use of albumin solution might be due to this lipofuscin.
D003116:Color; D004355:Drug Stability; D004356:Drug Storage; D006801:Humans; D008062:Lipofuscin / Q000009:adverse effects* / Q000032:analysis; D010860:Pigments, Biological / Q000009:adverse effects*; D012709:Serum Albumin / Q000009:adverse effects*; D012996:Solutions
D008062:Lipofuscin; D010860:Pigments, Biological; D012709:Serum Albumin; D012996:Solutions